AQR Capital Management - CYTOMX THERAPEUTICS INC ownership

CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 116 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
AQR Capital Management ownership history of CYTOMX THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$717,000
+705.6%
391,860
+2141.0%
0.00%
Q3 2021$89,000
-89.5%
17,486
-87.0%
0.00%
-100.0%
Q2 2021$850,000
+8.8%
134,285
+32.9%
0.00%0.0%
Q1 2021$781,000
-3.8%
101,008
-18.5%
0.00%0.0%
Q4 2020$812,000
+0.1%
123,929
+1.6%
0.00%0.0%
Q3 2020$811,000
-48.8%
121,992
-35.9%
0.00%
-66.7%
Q2 2020$1,585,000
+47.3%
190,325
+35.6%
0.00%
+50.0%
Q1 2020$1,076,000
-1.6%
140,339
+6.7%
0.00%
+100.0%
Q4 2019$1,093,000
+171.2%
131,558
+140.7%
0.00%
Q3 2019$403,000
-6.5%
54,658
+42.1%
0.00%
Q2 2019$431,000
+81.1%
38,457
+74.0%
0.00%
Q1 2019$238,000
-15.3%
22,101
+18.7%
0.00%
Q4 2018$281,000
-53.2%
18,619
-42.7%
0.00%
-100.0%
Q3 2018$601,000
-36.2%
32,490
-21.2%
0.00%0.0%
Q2 2018$942,000
-27.6%
41,213
-9.8%
0.00%0.0%
Q1 2018$1,301,000
-35.4%
45,712
-52.1%
0.00%
-50.0%
Q4 2017$2,014,000
+110.7%
95,387
+81.2%
0.00%
+100.0%
Q3 2017$956,000
+348.8%
52,636
+283.9%
0.00%
Q2 2017$213,00013,7110.00%
Other shareholders
CYTOMX THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 524,763$7,924,0003.84%
Congress Park Capital LLC 123,311$1,862,0002.05%
Perceptive Advisors 2,911,715$43,588,0001.66%
RTW INVESTMENTS, LP 908,586$13,720,0001.28%
HAMILTON LANE ADVISORS LLC 68,753$1,038,0000.91%
HARBOURVEST PARTNERS LLC 79,193$1,196,0000.57%
SPHERA FUNDS MANAGEMENT LTD. 273,151$4,125,0000.46%
Exane Asset Management 50,000$755,000,0000.44%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 622,548$9,400,0000.38%
Cormorant Asset Management, LP 296,712$4,480,0000.36%
View complete list of CYTOMX THERAPEUTICS INC shareholders